The 2026 AHA/ASA acute ischemic stroke guideline update expands emergency treatment eligibility by naming tenecteplase as an alternative thrombolytic, broadening endovascular thrombectomy criteria, and tightening post-reperfusion blood pressure targets. The changes are aimed at earlier and wider identification of appropriate patients in the emergency window. For stroke systems of care, the guideline revisions affect protocols for thrombolytic selection and thrombectomy referral thresholds, requiring coordinated updates across EMS, emergency departments, and interventional centers. The operational impact will likely be greatest where prehospital workflows, imaging capacity, and hemodynamic management protocols can be rapidly standardized. In parallel with this guideline evolution, translational work continues to focus on better prediction and imaging-aligned triage models—raising the bar for how quickly clinical teams can convert evidence into action.